MedTech Talent Recruitment

What does it really take to raise capital in a thriving MedTech ecosystem? In this exclusive webinar, Lifeblood’s Joseph Snyder, Co-Founder & Head of Talent, and Cristiano Fontana, Head of Advisory, explore what makes Ireland’s investment ecosystem so unique—and how emerging startups can apply these principles to become venture-backable. Through a dynamic conversation with leading Irish investors and founders—including Daniel O’Mahony (Partner at Seroba), Joey Mason (Venture Partner at Claret Capital Partners), and Tim Jones (CEO & Co-Founder of SymPhysis Medical)—this session unveils how trust, collaboration, and long-term alignment fuel successful fundraising in Ireland. From strategic talent planning to understanding how investors think, this webinar offers practical insights for MedTech founders looking to fundraise intentionally and scale with purpose.

Raising capital in MedTech is never easy, and understanding why an investor passes can be even harder. This episode of the Step-Up webinar series tackles the candid truths and tactical fixes behind the most common investor rejections. Whether you're a founder, operator, or aspiring innovator, this is a rare look behind the curtain. From fractured narratives and unclear IP strategy to team gaps and valuation misalignment, our expert panel walks through the pitfalls they see most—and how startups can avoid them. Hosted by: Cristiano Fontana Head of Advisory, Lifeblood Cristiano is a former MedTech founder and operator who now advises startups on investor readiness, commercialization strategy, and go-to-market execution. LinkedIn: https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/ Joseph Snyder Co-Founder & Head of Talent, Lifeblood Joseph specializes in building MedTech teams that scale. With a background in sales leadership and a decade of experience across startup growth and executive search, he guides companies in aligning hiring strategy with capital planning. LinkedIn: https://www.linkedin.com/in/josephasnyder1/ Featured Guests: Martin Gomez Partner, Goodwin Martin advises MedTech startups and investors on intellectual property, licensing, and transactional strategy. A registered patent attorney with a background in biomedical engineering, he’s a key player in IP positioning, design protection, and due diligence for both early-stage and high-growth companies. LinkedIn: https://www.linkedin.com/in/martin-gomez-898556113/ Thomas Busby Director, Outcome Capital With deep experience in healthcare M&A, capital strategy, and valuation, Thomas has guided dozens of startups and boards through transactions and financing events. He also serves on multiple innovation advisory boards and is a frequent contributor to MedTech publications. LinkedIn: https://www.linkedin.com/in/thomasbusbyiii/ Tracy MacNeal President & CEO, Materna Medical Tracy is a chemical engineer, investor, and serial entrepreneur leading Materna Medical, a women’s health company with breakthrough solutions in maternal care. She also serves on the Board of AdvaMed and champions health equity through innovation. LinkedIn: https://www.linkedin.com/in/tracymacneal/ Umaima Ahmad CEO & Co-founder, 52North Umaima is a MedTech founder and former life sciences dealmaker with expertise in billion-dollar licensing and M&A transactions. Her company, 52North, focuses on improving urgent care and was awarded breakthrough status by the UK government in 2024. LinkedIn: https://www.linkedin.com/in/umaima-ahmad/ In this session, we unpack: The most common blind spots that lead investors to say no How to align your story, team, and IP for stronger fundraising outcomes What investors actually want to see—and how to deliver it If you’ve ever wondered what’s holding your pitch back, this is the conversation you need to hear.

In MedTech, relationships can be the difference between stalled progress and breakthrough success. Whether you're raising capital, preparing for diligence, or navigating M&A, your network matters. This Step-Up webinar from Lifeblood explores how early-stage MedTech companies can build meaningful connections that drive business outcomes. Join us as we talk with experts who live at the intersection of innovation, investment, and community building. Featured Speakers: Stephen Levin Editor-in-Chief, MedTech Strategist & Managing Partner, Innovation In Medtech, LLC With 25+ years covering the global MedTech landscape, Stephen brings deep industry insight and a sharp eye for trends shaping the future of medical innovation. LinkedIn: https://www.linkedin.com/in/stephen-levin-3415a591/ Paul Grand Founder & CEO, MedTech Innovator Paul leads the world’s largest MedTech accelerator and has spent his career helping startups secure funding, gain visibility, and scale with purpose. LinkedIn: https://www.linkedin.com/in/paulgrand/ Ken Nelson Partner, MedTech Advantage Fund Ken has helped scale and exit multiple MedTech startups, raising over $100M in venture capital while leading global commercialization strategies in cardiac monitoring and digital health. LinkedIn: https://www.linkedin.com/in/ken-nelson-56aaa34/ Joseph Snyder Co-Founder & Head of Talent, Lifeblood Joseph builds winning teams for MedTech startups and public companies. He brings over a decade of sales and talent leadership experience, with a focus on strategic growth and industry alignment. LinkedIn: https://www.linkedin.com/in/josephasnyder1/ Cristiano Fontana Head of Advisory, Lifeblood Cristiano is a former founder and MedTech operator who now advises startups on business strategy, investor readiness, and go-to-market execution. LinkedIn: https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/ If you’re building in MedTech and ready to expand your network, this conversation is your next step forward.

In a market defined by rapid innovation and economic uncertainty, knowing where capital is flowing and why, can give founders and investors a critical edge. This episode of the MedTech Step-Up webinar series delivers real-time insights into the current state and future outlook of MedTech investment. Whether you're raising your first round or advising others on capital strategy, this session is packed with practical guidance from seasoned investors and operators who know what it takes to succeed in today’s environment. Hosted by: Joseph Snyder Co-Founder & Head of Talent, Lifeblood Joseph builds winning teams for MedTech startups and public companies. He brings over a decade of sales and talent leadership experience, with a focus on strategic growth and industry alignment. LinkedIn: https://www.linkedin.com/in/josephasnyder1/ Cristiano Fontana Head of Advisory, Lifeblood Cristiano is a former founder and MedTech operator who now advises startups on business strategy, investor readiness, and go-to-market execution. LinkedIn: https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/ Featured Guests: David Uffer Managing Director, Trinity Life Sciences With over 30 years of executive-level experience in MedTech strategy, venture investing, and M&A, David offers a panoramic view of capital markets and commercialization strategies across devices, diagnostics, and digital health. LinkedIn: https://www.linkedin.com/in/david-uffer-00a176/ Jonathan Norris Managing Director, VC Relationship Management, HSBC Innovation Banking Jonathan is a respected voice in healthcare venture capital, providing data-driven guidance to founders and investors alike. His expertise spans fundraising, IPO trends, M&A, and capital flow analysis. LinkedIn: https://www.linkedin.com/in/jonathan-norris-248556 Diana Saraceni Founder & Managing Partner, Panakes Partners A veteran venture capitalist with a pan-European portfolio, Diana has led dozens of successful investments in healthcare and deep tech. She is a passionate advocate for innovation, equity, and scale across the MedTech landscape. LinkedIn: https://www.linkedin.com/in/diana-saraceni-74994/ In this session, we explore: How macroeconomic trends are reshaping capital strategy in MedTech What types of companies investors are prioritizing in 2025 and beyond How founders can position themselves to raise effectively in a shifting environment If you’re building or backing the next wave of MedTech innovation, this conversation is essential.

In this dynamic episode, Joseph Snyder (Co-Founder & Head of Talent at Lifeblood) and Cristiano Fontana (Head of Advisory at Lifeblood) lead a powerful conversation exploring the pivotal role of AI in the future of MedTech startups. They’re joined by a panel of industry experts, including: Darcy Bachert – Founder & CEO of ProLucid, an ISO 13485-certified firm specializing in custom medical software development Alex Condon – COO of Matrix One and former Co-Founder of Galen Data, a globally compliant medical device cloud platform acquired by Matrix One Marty Gomez – Partner at Goodwin, leading their MedTech and AI practice across IP, company formation, licensing, fundraising, and strategic transactions Together, they unpack what’s hype versus what’s real, covering: -Regulatory expectations and FDA guidance -AI’s impact on product development and investor outlook -Best practices for integrating AI responsibly Whether you’re a founder, investor, or industry partner, this session delivers practical insight on how to navigate the evolving AI landscape in MedTech. Tune in and stay ahead of what’s next.